SR biotek Inc. (XKON:270210)

ANSYS Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2016	FY 2015
Period Ending	Dec 31, 2016	Dec 31, 2015
Operating Revenue	1,620	1,876
Other Revenue	-	-0
Revenue	1,620	1,876
Revenue Growth (YoY)	-13.66%	-
Cost of Revenue	875.39	919.11
Gross Profit	744.58	957.27
Selling, General & Admin	597.16	413.23
Other Operating Expenses	22.51	20.35
Operating Expenses	693.03	497.75
Operating Income	51.55	459.52
Interest Expense	-51.2	-53.5
Interest & Investment Income	1.52	0.17
Currency Exchange Gain (Loss)	8.57	3.18
Other Non Operating Income (Expenses)	-85.01	-18.3
EBT Excluding Unusual Items	-74.56	391.08
Gain (Loss) on Sale of Assets	-	78.19
Pretax Income	-74.56	469.27
Income Tax Expense	2.42	8.19
Net Income	-76.98	461.08
Net Income to Common	-76.98	461.08
Shares Outstanding (Basic)	0	0
Shares Outstanding (Diluted)	0	0
Shares Change (YoY)	0.02%	-
EPS (Basic)	-1924.04	11527.24
EPS (Diluted)	-1924.04	11527.24
Free Cash Flow	22.43	-1,531
Free Cash Flow Per Share	560.53	-38285.18
Gross Margin	45.96%	51.02%
Operating Margin	3.18%	24.49%
Profit Margin	-4.75%	24.57%
Free Cash Flow Margin	1.38%	-81.61%
EBITDA	300.9	649.36
EBITDA Margin	18.57%	34.61%
D&A For EBITDA	249.35	189.85
EBIT	51.55	459.52
EBIT Margin	3.18%	24.49%
Effective Tax Rate	-	1.75%
Advertising Expenses	59.48	54.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.